Published online April 1, 2008
PEDIATRICS Vol. 121 No. 4 April 2008, pp. 703-710 (doi:10.1542/peds.2007-1130)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (1)
Google Scholar
Right arrow Articles by Healy, C. M.
Right arrow Articles by Baker, C. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Healy, C. M.
Right arrow Articles by Baker, C. J.
Related Collections
Right arrow Infectious Disease & Immunity

ARTICLE

Fluconazole Prophylaxis in Extremely Low Birth Weight Neonates Reduces Invasive Candidiasis Mortality Rates Without Emergence of Fluconazole-Resistant Candida Species

C. Mary Healy, MDa,b, Judith R. Campbell, MDa,b, Elena Zaccaria, CICb and Carol J. Baker, MDa,b,c

Departments of a Pediatrics
c Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas
b Woman's Hospital of Texas, Houston, Texas

OBJECTIVE. We evaluated the impact of fluconazole prophylaxis for extremely low birth weight infants on invasive candidiasis incidence, invasive candidiasis-related mortality rates, and fluconazole susceptibility of Candida isolates.

METHODS. Extremely low birth weight infants <5 days of age, except those with liver dysfunction, were eligible for fluconazole prophylaxis. NICU infants (all birth weights) with invasive candidiasis between April 2002 and March 2006 were compared with those with invasive candidiasis before fluconazole prophylaxis (2000–2001).

RESULTS. Twenty-two infants had invasive candidiasis (all candidemia) during fluconazole prophylaxis; before fluconazole prophylaxis, there were 19 cases (candidemia: 17 cases; meningitis: 2 cases). Invasive candidiasis incidence in NICU infants decreased from 0.6% (19 of 3012 infants) before fluconazole prophylaxis to 0.3% (22 of 6393 infants) in 2002–2006 and that in extremely low birth weight infants decreased 3.6-fold. No Candida-attributable deaths occurred during 2002–2006 fluconazole prophylaxis, compared with 4 (21%) before fluconazole prophylaxis. The onset of invasive candidiasis was later during 2002–2006 (23.5 vs 12 days), but risk factors were similar. The invasive candidiasis species distribution remained stable. Of 409 infants who received fluconazole prophylaxis, 119 (29%) received 42 days. Shorter fluconazole prophylaxis duration was related to intravenous access no longer being necessary in 242 cases (59%), noninvasive candidiasis-related death in 29 (7%), hospital transfer in 8 (2%), invasive candidiasis diagnosis in 8 (2%), and transient increase in serum transaminase levels in 4 (1%). One hundred twenty-seven infants (31%) who received fluconazole prophylaxis developed cholestasis during hospitalization, two thirds of whom had other predisposing conditions. On multivariate logistic regression necrotizing enterocolitis and increasing days of total parenteral nutrition, but not increasing number of doses on days of fluconazole, were significantly associated with the development of cholestasis.

CONCLUSION. During 4 years of fluconazole prophylaxis, the incidence of invasive candidiasis and invasive candidiasis-associated mortality rates in extremely low birth weight infants were reduced significantly, without the emergence of fluconazole-resistant Candida species.

Key Words: neonates • extremely low birth weight • Candida infection • fluconazole prophylaxis • resistance

Abbreviations: VLBW—very low birth weight • IC—invasive candidiasis • ELBW—extremely low birth weight • FP—fluconazole prophylaxis • CVC—central vascular catheter • BW—birth weight • TPN—total parenteral nutrition • MIC—minimal inhibitory concentration

Accepted Aug 29, 2007.




This article has been cited by other articles:


Home page
 JWatch Infect. DiseasesHome page
Fluconazole to Prevent Invasive Candidiasis in Tiny Preemies
Journal Watch Infectious Diseases, April 23, 2008; 2008(423): 5 - 5.
[Full Text]

Home page
 PediatricsHome page
D. K. Benjamin Jr
First, Do No Harm
Pediatrics, April 1, 2008; 121(4): 831 - 832.
[Full Text] [PDF]